Raf Mols
Impact in
- Pharmaceutical Science top 0.2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Gastroenterology top 2%
- Gastrointestinal motility and disorders
Papers in
- Oncology 17
- Drug Transport and Resistance Mechanisms 15
-
- Drug Solubulity and Delivery Systems 15
- Advanced Drug Delivery Systems 9
- Co-authors
- Patrick Augustijns (46 shared papers)Pieter Annaert (16 shared papers)Eric Schoenmakers (6 shared papers)Jörn Bullerdiek (5 shared papers)Jan Tack (15 shared papers)Sylke Wanschura (3 shared papers)Wim J.M. Van de Ven (1 shared paper)Joachim Brouwers (13 shared papers)
- Journals
- International Journal of Pharmaceutics (8 papers)European Journal of Pharmaceutics and Biopharmaceutics (4 papers)Journal of Pharmaceutical Sciences (4 papers)European Journal of Pharmaceutical Sciences (4 papers)Pharmaceutics (3 papers)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Raf Mols
55 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 120
- Pharmaceutical Science 819
- Gastroenterology 184
- Oncology 527
- Obstetrics and Gynecology 116
- Infectious Diseases 257
Countries citing papers authored by Raf Mols
This map shows the geographic impact of Raf Mols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raf Mols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raf Mols more than expected).
Fields of papers citing papers by Raf Mols
This network shows the impact of papers produced by Raf Mols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raf Mols. The network helps show where Raf Mols may publish in the future.
Co-authors
The 25 scholars most cited alongside Raf Mols, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 475 | |
| 2 | 2015 | 209 | |
| 3 | 2008 | 201 | |
| 4 | 2007 | 201 | |
| 5 | 2010 | 178 | |
| 6 | 1996 | 158 | |
| 7 | 2010 | 106 | |
| 8 | 2003 | 98 | |
| 9 | 2022 | 88 | |
| 10 | 2008 | 72 | |
| 11 | 2020 | 68 | |
| 12 | 2005 | 64 | |
| 13 | 2008 | 60 | |
| 14 | 1994 | 54 | |
| 15 | 2009 | 53 | |
| 16 | 2011 | 53 | |
| 17 | 2013 | 48 | |
| 18 | 2016 | 41 | |
| 19 | 2004 | 40 | |
| 20 | 2021 | 35 |
About Raf Mols
Raf Mols is a scholar working on Oncology, Pharmaceutical Science, Pediatrics, Perinatology and Child Health, Surgery and Molecular Biology, having authored 55 papers that have together received 2.9k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (15 papers), Drug Transport and Resistance Mechanisms (15 papers), Advanced Drug Delivery Systems (9 papers), Pharmacological Effects and Toxicity Studies (7 papers), Gastrointestinal motility and disorders (6 papers), HIV/AIDS drug development and treatment (5 papers), Pharmaceutical studies and practices (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Pharmaceutical Science (819 citations), Gastroenterology (184 citations), Oncology (527 citations), Obstetrics and Gynecology (116 citations) and Infectious Diseases (257 citations). Raf Mols has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Patrick Augustijns, Pieter Annaert, Eric Schoenmakers, Jörn Bullerdiek, Jan Tack, Sylke Wanschura, Wim J.M. Van de Ven, Joachim Brouwers, Herman Van den Berghe and Jan Van Humbeeck. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.